期刊文献+

Dukes’A、B期结直肠癌COX-2表达与复发转移的关系 被引量:1

下载PDF
导出
摘要 目的:探讨Dukes’A、B期结直肠癌环氧化酶-2(cyclooxygenase-2,COX-2)表达与术后复发转移的关系。方法:收集1989-1999年88例行根治性手术的结直肠腺癌病例,Dukes’A期26例,Dukes’B期62例,分为复发转移组和非复发转移组各44例。两组在肠壁浸润深度、性别、年龄、肿瘤部位等情况相似。应用免疫组化方法检测原发瘤组织中COX-2表达。结果:复发组COX-2阳性率为79.5%(35/44),无复发组COX-2阳性率为81.8%(36/44),两组阳性率比较差异无统计学意义(P=0.787)。结论:Dukes’A、B期结直肠癌术后复发转移可能与COX-2表达无关。
出处 《广西医科大学学报》 CAS 北大核心 2008年第1期73-74,共2页 Journal of Guangxi Medical University
基金 广西自然科学基金项目(No0542051)
  • 相关文献

参考文献3

二级参考文献48

  • 1Williams CS, Mann M, DuBios RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18:7908-7916.
  • 2Egil F. Biochemistry of cyclooxygenase (COX-2) inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000; 37:431-502.
  • 3Subbaramaiah K, Dannenberg AJ. Cyclooxygenase2: a molecular target for cancer prevention and treatment. Trends Pharmaco Sci 2003; 24: 96-102.
  • 4Thun MJ, Hennekenn CH. Aspirin and other non-steroidal antiinflammatory drugs and the risk of cancer development. In:DeVitt VT, Hellman S, Rosenberg SA. Cancer: principles and pracrice of oncology. 6^th edition. Philadelphia: Lippincott Williams &Wilkins Press, U S A 2001:601-607.
  • 5Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998: 58:409412.
  • 6Reddy BS, Rao CV, Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 1996; 56:4566-4569.
  • 7Dannenberg AJ, Zakim D. chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin Oncol 1999;26:499-504.
  • 8Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
  • 9Dicato M, Berchem G, Duhem C, Ries F. The biology of colorectal cancer. Semin Oncol 2000; 27(5 Suppl 10): 2-9.
  • 10Kononen J, Bubendorf L, Kalliolniemi A, Barlund M, Schraml P,Leighton S, Torhorst J, Mihatsch MJ, Sauter G, KaUioniemi OP.Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat ivied 1998; 4:844-847.

共引文献39

同被引文献15

  • 1Gasparini G,Longo R,Sarmieto R,et al. Inhibitors of eyclo-oxygenase 2: a new class of anticancer agents. Lancet Oncol,2003,4 ( 10): 605-615.
  • 2Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochem Biophysic Aeta,2000, 1470: M69-M78.
  • 3Sheehan KM,Sheahan K,O'Donoghue DP,et al. The relationship between Cyclooxygenase-2 expression and colorectal cancer. J Am Med Assoc, 1999,282: 1254-1257.
  • 4Knosel T, Yu Y,Stein U,et al. Overexpression of cyclooxygenase- 2 correlates with chromosomal gain at the cyclooxygenase-2 locus and decreased patient survival in advanced colorectal carcinomas. Dis Colon Rectum,2004,47( 1 ): 70-77.
  • 5Yamauchi T, Watanabe M,Kubota T,et al. Cyelooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum, 2002,45: 98-103.
  • 6Eberhart CE,Coffey RJ,Radhika A,et al. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterol, 1994,107:1183-1188.
  • 7Dixon DA,Tolley ND,King PH,et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest,2001,108: 1657-1665.
  • 8Fujita T,Matsui M,Takaku K,et al. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res, 1998,58: 4523-4826.
  • 9Sankhasard S,Lertprasertsuk N,Vinitketkumneun U,et al. Expression of cyclooxygenase-1 and -2 and clinicopathologic features of colorectal cancer in northern Thailand. Asian Pac J Cancer Prey,2004,5(1): 44-49.
  • 10Masunaga R, Kohno H, Dhar DK,et aI. Cyclooxygenase-2 expression correlates wuth tumour neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res, 2000, 6: 4064-4068.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部